Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. 15342446 Sit AS, Modugno F, Hill LM, Martin J, Weissfeld JL Cancer Epidemiol. Biomarkers Prev. 2004 PLCO
Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. 15265970 Taylor KL, Shelby R, Gelmann E, McGuire C J. Natl. Cancer Inst. 2004 PLCO
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: biopsy rates and cancer characteristics of initial (T0) screen. Andriole GL, Pinsky PF, Levin DL, Gelmann EP, Crawford ED, Reding DJ, Prorok PC, Gohagan J. Urol. 2004 PLCO
Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence. 12540500 Ford ME, Havstad SL, Flickinger L, Johnson CC Cancer Epidemiol. Biomarkers Prev. 2003 PLCO
Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. 12727673 Pinsky PF, Kramer BS, Reding D, Buys S, PLCO Project Team Am. J. Epidemiol. 2003 PLCO
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. 12737857 Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team Lancet 2003 PLCO
Results of repeat sigmoidoscopy 3 years after a negative examination. 12837710 Schoen RE, Pinsky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, Gohagan JK, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Group JAMA 2003 PLCO
Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. 15017502 Pinsky PF, Schoen RE, Weissfeld JL, Bresalier RS, Hayes RB, Gohagan JK Clin. Gastroenterol. Hepatol. 2003 PLCO
The impact of item order on ratings of cancer risk perception. 12101113 Taylor KL, Shelby RA, Schwartz MD, Ackerman J, LaSalle VH, Gelmann EP, McGuire C Cancer Epidemiol. Biomarkers Prev. 2002 PLCO
Whole blood cryopreservation in epidemiological studies. 12433734 Hayes RB, Smith CO, Huang WY, Read Y, Kopp WC Cancer Epidemiol. Biomarkers Prev. 2002 PLCO
Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. 11774270 de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH, European Randomized Screening for Prostate Cancer (ERSPC) Trial, International Prostate … Int. J. Cancer 2002 PLCO
Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women. 12050100 Schoen RE, Schragin J, Weissfeld JL, Thaete FL, Evans RW, Rosen CJ, Kuller LH Cancer Epidemiol. Biomarkers Prev. 2002 PLCO
Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. 12173322 Weissfeld JL, Ling BS, Schoen RE, Bresalier RS, Riley T, Prorok PC, Prostate, Lung, Colorectal, and Ovarian Project Team Cancer 2002 PLCO
Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. 11207159 Subar AF, Ziegler RG, Thompson FE, Johnson CC, Weissfeld JL, Reding D, Kavounis KH, Hayes RB, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Investigators Am. J. Epidemiol. 2001 PLCO
Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial. 11677101 Miller AB, Madalinska JB, Church T, Crawford D, Essink-Bot ML, Goel V, de Koning HJ, Määttänen L, Pentikäinen T Eur. J. Cancer 2001 PLCO
Relationship of demographic and clinical factors to free and total prostate-specific antigen. 11597539 Gelmann EP, Chia D, Pinsky PF, Andriole GL, Crawford ED, Reding D, Hayes RB, Kramer BS, Woodrum DL, Gohagan JK, Levin DL, PLCO Screening Trial Investigators Urology 2001 PLCO
Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 11189689 Stallings FL, Ford ME, Simpson NK, Fouad M, Jernigan JC, Trauth JM, Miller DS, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team Control Clin Trials 2000 PLCO
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. 11189687 Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, Caporaso N, Ziegler RG, Johnson CC, Weissfeld JL, Hoover RN, Hartge P, Palace C, Gohagan JK, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team Control Clin Trials 2000 PLCO
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 11189691 Miller AB, Yurgalevitch S, Weissfeld JL, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team Control Clin Trials 2000 PLCO
Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial. 11084571 Hartge P, Hayes R, Reding D, Sherman ME, Prorok P, Schiffman M, Buys S Am. J. Obstet. Gynecol. 2000 PLCO